A group of inheritors takes charge with new ideas and new strategies.
India’s venerated $37 billion pharma industry is at the crossroads. The road to new drug discovery – after decades of disappointing results – is famously pot-holed and, with half-discoveries being touted as new drugs, appears to be leading nowhere; The road to money-spinners such as Para-IV exclusivity, generic-generics and branded generics is facing rapid speed-breakers of competition, commoditisation and price erosion. In the interim, domestic pharma majors went on the road to tactical M&As to foster growth. But the most promising road is the way to complex generics, specialty drugs and bio-similars. It is also the most arduous, requiring a decoction of cutting-edge science, speed and agility and outstanding selling prowess – neither of which is Indian pharma majors’ strength.
That calls for reassessing the ground realities and implementation of new strategies, fresh thinking and, most importantly, fresh blood. Just as the doctor ordered, the scions – some second generation and some third – of Indian pharma majors are readying to take on this onerous responsibility.
This is a watershed moment. If they succeed, India will still have a home-grown pharmaceutical industry. If they don’t, the domestic pharma landscape will be peppered with foreign-owned Indian pharma companies, a trend that has accelerated since the beginning of this decade.
This story is from the May 21, 2017 edition of Business Today.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the May 21, 2017 edition of Business Today.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
It's Personal
Mixing work and personal tasks on work machines may be a done thing for many, but it makes sense to have a dedicated device for your personal needs. Here are two such devices
INTO THE BLUE
For WTiCabs Founder and CEO Ashok Vashist, scuba diving is not just an adventure sport. It is a pathway to connect with the ocean
"Challenges are opportunities"
AMIT JAIN CO-FOUNDER & CEO CARDEKHO GROUP CarDekho Group is a digital automotive solutions provider
THE WAIT FOR HIGHER PENSION
ALMOST 18 MONTHS AFTER THE SUPREME COURT RULING, SUBSCRIBERS WHO OPTED FOR A HIGHER PENSION UNDER THE EMPLOYEES' PENSION SCHEME CONTINUE TO WAIT AS THE EPFO, FACING A STAFF CRUNCH, TRIES TO FIGURE OUT THE MATH
"It's possible to have a 25% growth out of India from now on"
Rail Europe Executive Chairman & CEO Björn Bender talks about the India market, the shift to digital, and the way ahead
Evolving Strategies
Companies need to adapt to changing times for a strong workforce
PERKS PRESSURE
IT'S NOT JUST ABOUT THE MONEY ANYMORE FOR EMPLOYEES. FROM FOUR-DAY WORK WEEKS, TO SKILLING ON THE JOB AND MENTAL WELL-BEING EXERCISES, COMPANIES ARE OFFERING A HOST OF BENEFITS TO RETAIN TOP TALENT. IS THIS ENOUGH?
Turning Over a New Leaf
The integration of mortgage giant HDFC Ltd with HDFC Bank sets the stage for making the best of both worlds
THE FLEXIBILITY TO EXCEL
By offering employees multiple ways by which they can work and grow, Google has ensured that it gets the best from them
All About 'Learning & Training'
L&T provides its employees with a variety of programmes to help them grow professionally and climb the corporate ladder